-
Balance Sheet
The activity Crosmac Biotech (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was completed.
-
Director Appointment
Mahadev Prasad Yadav was appointed as a Director was appointed as a Director on 20 Oct 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
-
Company Incorporation
Crosmac Biotech (Opc) Private Limited was registered on 20 Oct 2020 with Roc Patna & aged 5 years 3 months as per MCA records. was recorded as a recent event.
Crosmac Biotech (Opc) Private Limited - Company Profile
Crosmac Biotech (Opc) Private Limited, Engaging in manufacturing within the chemicals sector, it holds CIN: U24230BR2020OPC048757. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mahadev Prasad Yadav (Director). Its latest balance sheet filed on 31 March 2024. It is based at 02, Infront Of Sr Joseph Dalsingsarai, Chaklokman, Samastipur, Bihar, 848114.
Company Details
- CIN/LLPIN
U24230BR2020OPC048757
- Registration Number
048757
- Incorporation Date
20 October 2020
- Authorized Capital
₹0.10 M
- Paid-Up Capital
₹0.10 M
- ROC Code
Roc Patna
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.46%
- Profit Growth -5292.31%
- Ebitda -152.39%
- Net Worth -15.48%
- Total Assets -14.16%
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahadev Prasad Yadav | Director | 20 Oct 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crosmac Biotech (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.46% increase. The company also saw a substantial fall in profitability, with a 5292.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.48%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
Unlock access to Crosmac Biotech (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Crosmac Biotech (Opc) has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Crosmac Biotech (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crosmac Biotech (Opc)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Crosmac Biotech (Opc) Private Limited?
The CIN of Crosmac Biotech (Opc) Private Limited is U24230BR2020OPC048757.
Where is Crosmac Biotech (Opc) Private Limited headquartered?
Crosmac Biotech (Opc) Private Limited is headquartered at 02, Infront Of Sr Joseph Dalsingsarai, Chaklokman, Samastipur, Bihar, 848114.
When was Crosmac Biotech (Opc) Private Limited incorporated?
Crosmac Biotech (Opc) Private Limited was incorporated on 20 October 2020.
Who are the current directors of Crosmac Biotech (Opc) Private Limited?
The current directors of Crosmac Biotech (Opc) Private Limited are
What is the primary industry of Crosmac Biotech (Opc) Private Limited?
The primary industry of Crosmac Biotech (Opc) Private Limited is Chemicals.
Is Crosmac Biotech (Opc) Private Limited a listed company?
Crosmac Biotech (Opc) Private Limited is unlisted.
What is the capital structure of Crosmac Biotech (Opc) Private Limited?
The authorized capital of Crosmac Biotech (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
+91-XXXXXXXXXX